It has shown an improvement in ventricular function by counteracting the detrimental effects of renin–angiotensin–aldosterone system (RAAS) activation and blocking neprilysin to degrade endogenous natriuretic peptides, and has demonstrated benefits in patients with mild-to-moderate arterial hypertension and heart failure (Mangiafico et al., 2013). Here, MME is linked to heart failure.